InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (19 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
19
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Stankovich Thomas, Chief Financial Officer. Director active across 1 company, notably ReShape Lifesciences Inc.. Cumulatively, 26 filings have been published. Breakdown: 4 buys · 19 sells. Total volume traded: €182k. History available since 15 June 2021. The latest transaction was filed on 30 November 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Stankovich Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
39 shares@ US$0.230.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-24-000059:0
108 shares@ US$1.430.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000110:0
106 shares@ US$1.470.0% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000077:0
109 shares@ US$2.600.1% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000075:0
48 shares@ US$7.490.1% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-23-000030:0
364,756 shares0Common Stock, $0.001 par value per shareSEC:0001235802-22-000136:0
5,883 shares@ US$0.27250.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000119:0
5,809 shares@ US$0.28070.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000112:0
4,828 shares@ US$0.390.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000109:0
4,728 shares@ US$0.470.6% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000092:0
4,630 shares@ US$0.550.7% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000081:0
4,478 shares@ US$0.961.2% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000077:0
78 shares@ US$0.870.0% of flowCommon Stock, $0.001 par value per shareSEC:0001104659-22-067045:0
Canonical exit: 29 Aug 2022 (T+90)
4,529 shares@ US$0.771.7% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000058:0
5,038 shares@ US$1.132.7% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000045:0
3,658 shares@ US$1.061.8% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000035:0
3,684 shares@ US$1.222.1% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000021:0
3,171 shares@ US$1.782.6% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-22-000019:0
4,304 shares@ US$1.8273.6% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000140:0
20,000 shares@ US$2.0218.4% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000132:0
Canonical exit: 16 Feb 2022 (T+90)
4,320 shares@ US$2.695.2% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000130:0
3,660 shares@ US$2.764.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000128:0
282,382 shares0Common Stock, $0.001 par value per shareSEC:0001790300-21-000010:0
15,000 shares@ US$3.42922.5% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000116:0
Canonical exit: 28 Nov 2021 (T+90)
15,000 shares@ US$3.21921.3% of flowCommon Stock, $0.001 par value per shareSEC:0001235802-21-000111:0
Canonical exit: 18 Nov 2021 (T+90)
25 of 26 declarations
About Stankovich Thomas
STANKOVICH THOMAS is Directeur Financier and Chief Financial Officer at ReShape Lifesciences Inc. The record shows 26 filings, and across the sampled recent filings from 2021-06-17 to 2024-08-13, the cumulative amounts are EUR 120701 in buys and EUR 72988 in sells, with a modal transaction nature of disposal.
